Donate Now
Ranin Soliman: Pioneering Evidence-Based Healthcare for Childhood Cancer in Egypt
Ranin Soliman, a dedicated scholar, recently achieved a remarkable milestone in her academic journey by obtaining her DPhil (PhD) in Evidence-based Healthcare from the prestigious Centre for Evidence-Based Medicine at the University of Oxford. Her groundbreaking research, generously sponsored by the Egypt Cancer Network 57357, promises to revolutionize the landscape of childhood cancer care […]
A Mother’s Journey at Hospital 57357: Finding Hope Amidst Despair
When Jana fell ill three years ago, our family embarked on a desperate search for answers. Despite visiting numerous hospitals in Bani Soueif, her condition only deteriorated, leaving us feeling helpless. With limited resources and a heart heavy with worry, I, along with my husband, worked tirelessly in the fields to afford the necessary tests, […]
Lamar’s Courageous Battle: Fighting Cancer for the Second Time While Dreaming of Becoming a Vet
Lamar, a resilient member of 57357’s community, exudes determination, endurance, and hope as she faces cancer for the second time. At just nine years old, her radiant smile belies the challenges she has overcome. Diagnosed with a brain tumor in 2018, Lamar lost her eyesight, yet her spirit remained unbroken through two years […]
Empowering Pediatric Oncology Fellows: A Collaborative Initiative by Hospital 57357 and Dana Farber Boston Children’s Cancer Center
Supported by ECN 57357, the collaboration between Hospital 57357 and Dana Farber Boston Children’s Cancer and Blood Disorders Center (DFBC) has yielded a transformative pediatric oncology fellowship program and its sub-specialties, empowering trainees to drive change in their respective settings through research and innovation. Over 28 graduates from Egypt, Africa, and Arab countries have […]
Meet Hana, the young protagonist of 57357, whose journey is filled with courage, hope, and resilience as she awaits a bone marrow transplant.
At the age of 8, Hana was admitted to 57357 hospital two years ago, where she was diagnosed with a tumor in her adrenal gland and kidney. Despite enduring intensive chemotherapy and surgery to remove part of the tumor and intestine, Hana’s determination shines through as she continues her battle against the illness. Her dream? […]
Acquisitions in the laboratory of the Children’s Cancer Hospital 57357 in Egypt have been accredited by the American Society of Pathologists (CAP). This accreditation, awarded by the Accredited Laboratory Committee of CAP, is based on a thorough assessment conducted on-site as part of CAP’s accreditation program.
The accreditation ensures that the hospital meets rigorous standards set by CAP, potentially impacting various units within the hospital, including those for blood analysis, blood chemistry, technology analysis, granule cell research, cytogenetics, molecular studies, microbiology analysis, immune genetics, tissue compatibility, and analytical assessments. Dr. Sherif Abu El-Naga, CEO of 57357 Group, emphasized that […]
A delegation from King Hussein Cancer Center visits 57357 to explore channels of cooperation specially in the field of research
Hospital 57357 welcomed a delegation from King Hussein Cancer Center in Jordan that included Dr. Amal Elamri, head of scientific affairs and research in the Center and Dr. Maisaa Elhusseiny, head of the Center’s pathology department, on a visit that spanned two days during which they toured the Hospital’s different sections and met with the […]
Thanks to ECN,US supporters, Hospital 57357 acquires the Atellica solution and Decapper for meeting growing diagnostic services of the community.
Recently, 57357’s automated labs have encountered difficulties related to availability of essential reagents and spare parts, causing delays in diagnosis and treatment for our patients. To address this issue and ensure uninterrupted service, it was necessary to invest in an additional chemistry and immunology instrument from a different brand. By diversifying our equipment portfolio, […]
In collaboration with the Egyptian Pediatric Hematology Oncology Society, EPHOS: Hospital 57357 organized the second annual international conference around the future of pediatric hematology oncology The conference was held in attendance of prof. Dr. Sherif Abouel Naga, 57357 group CEO and the Hospital’s general manager as honorary president of the
Hospital 57357 organized the second annual international conference around the future of pediatric hematology oncology The conference was held in attendance of prof. Dr. Sherif Abouel Naga, 57357 group CEO and the Hospital’s general manager as honorary president of the conference, Prof. Dr. Alaa Elhadad, the conference president and head of pediatric oncology department at […]
After passing the end of high school exam with a rate of 92.5%, Fatema shares:
I was fighting cancer for 9 years …Hospital 57357 is my home and my support. Today, I am 17 years old. I’ve been receiving treatment in 57357 for 9 years, which means that 57357 became my second home where I spent half of my age. My case was tough, a tumor in the eye, 3 […]
A research team at Hospital 57357 discovers markers that would help predict the outcome a rare type of pediatric tumors
The study opens the door to develop a targeted therapy for this disorder Within the framework of Hospital 57357’s pursuit to link research to clinical reality and concerns and its efforts to find solutions to improve survival rates, a research team discovered new agents that would help predict the development of a rare type of […]
Mesk is a 57357 champion who is fighting cancer and starting the follow up stage to realize the dream of cure
Mesk’s mother: “In 57357 there are angels who make our children’s journey with cancer much easier. This Hospital provides hope in cure to our children, may God protect it and its entire staff” With the help of every supporting hand, be it care providers or donors, 57357 fighters’ determination to defeat cancer is increased. Our […]
Sixteen years have already gone by since the inception of our home, Hospital 57357
Education, quality, and commitment are the secret behind success It is a festive day when a child completes his treatment and is on the road to cure Today, 7/7/2023, we celebrate the anniversary of the start of operation at Hospital 57357, the home that we built with a lot of effort and determination. In which […]
The Eid is always a blessed time of joyful gatherings and celebrations with family and friends.
This year our joy is manifold: we are celebrating two occasions: the Eid Alkebir and the 16th year of operation of Hospital 57357 On the 7th of July 2023, we shall celebrate the 16th anniversary of Hospital 57357’s inception. Thousands of children who have defeated cancer and have returned back to their normal lives, received education, graduated and […]
To affirm 57357’s global stature and the leadership of its clinical pharmacy department: A training program for students of Pharmacy, Texas University, in Hospital 57357’s clinical pharmacy department
In recognition of Hospital 57357’s standing, and the leadership of its clinical pharmacy department, the Hospital is currently hosting a delegation of students of Texas University’s school of Pharmacy , to receive a training course in Hospital 57357’s clinical pharmacy department which includes more than 30 specialties and highly experienced professionals. The training program is organized by […]
Within the framework of a collaboration between St. Jude Children’s Research Hospital, US and Hospital 57357: Graduation of a contagious diseases and infection control international program cohort
Hospital 57357 celebrated the graduation of a cohort of trainees enrolled in the international program of contagious diseases and infection control that was organized by St. Jude’s Global School, in cooperation with Hospital 57357. 57357 participation in this program is considered as worldwide recognition of its stature and potential, and that it became an accredited […]
Children’s Cancer Hospital 57357 received the visit of Prof. Dr. Hisham El Seify, member of the Board of Directors of Hospital 57357 Foundation and President of Egypt cancer network USA.
During the visit, Dr. Hisham El Seify visited various departments inside the hospital and the new Cyberknife treatment technology building, in addition to visiting the new creation center and new playing area funded with the support of the Egypt cancer network USA. Dr. Hisham El Seify said: In my frequent visits to Hospital 57357, I […]
Ayan’s mother: my son is receiving utmost care in 57357, and I started collecting donations from friends to support the other children
Ayan from Suez, is 4 years old. He started his treatment journey in Hospital 57357 a week ago. “We discovered Ayan’s sickness by chance, when he fell on his head while playing with his relatives”, shared Ayan’s mother. We hurried to the Hospital where he had x-rays on his arm, leg and brain. It was […]
During their recent visit to 57357: World cancer experts praise 57357’s acquisition and launch of the Cyberknife technology
Hospital 57357 welcomed the visits of Prof. Dr. Nobert Graf, professor of pediatric oncology in Saarland University, Germany, head of SIOP’s renal tumors work group & member of the Children’s Oncology Group, COG, in North America, Dr. Lee Cooper, pathology professor at Northwestern University, USA, and Dr. Zeinab Afifi, professor of pediatric oncology at Utah […]
Abdallah’s mother:” CCHE57357 is giving my son a fresh start’
Today we want to introduce you to Abdallah, another 57357 patient hero. Abdallah is a 6 year old active outgoing boy who loves to draw and to play soccer for his school’s football team. At the beginning of the academic year of 2021, the active player felt suddenly so sick that he couldn’t finish the […]
CCHE57357 posts a new research addressing patterns and outcomes of a rare syndrome when combined with neuroblastoma patients
A research study that included 15 Egyptian pediatric oncology patients addresses patterns and outcomes of Ataxia syndrome when accompanied by neuroblastoma published by a pediatric oncology consultant at CCHE57375. The Opsoclonus myoclonus ataxia syndrome (OMAS) is a rare primarily immune-mediated disease in the nervous system of children that is characterized by unusual movements of the […]
Patient Alaa praises 57357, saying: “CCHE57357 goes an extra mile to enable patients to defeat cancer ‘
In 2020, Alaa was 17 years old when she started suffering from a severe headache and continuous fever for a whole week. Then, she suddenly lost sight in one of her eyes. The following day her condition turned out to be even worse as she suddenly lost her hearing capacity of one ear. The regular […]
Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer
In collaboration with Tulane University, U.S., CCHE57357’s proteomics and metabolomics unit recently posted a research paper that demonstrates the relation between the presence of two protein complexes and the resistivity against chemotherapy used in the treatment of thyroid cancer patients. The study detected that some patients who suffered from thyroid cancer, were reported to have […]
A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients
CCHE genomics team recently published a research paper in the Cancer biomarker journal, that confirms the positive relevance /correlation between a specific gene expression in a patient’s blood and early tumor detection in AML patients Early detection contributes to better clinical outcomes for AML patients who make up to 20%of pediatric leukemia and account for […]
CCHE57357’s researchers conduct a systematic study to evaluate leukemia relapse treatment drugs in terms of effectiveness and cost
A systematic review Researchers at Children’s cancer Hospital 57357 conducted a systematic study to evaluate drugs used in treating acute leukemia relapse by linking their effectiveness to their economic cost. The study was published in Expert review of hematology magazine with an impact factor of 2.8 that was conducted in collaboration with the University of […]
